Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Outpatient, female or male aged ≥40 years, diagnosis of COPD with symptoms for at least 2 years
FEV1 ≤50% of predicted normal value, pre-bronchodilator, FEV1/VC \<70%
Pre-bronchodilator
You may not be if
Current respiratory tract disorder other than COPD
History of asthma or rhinitis
Significant or unstable cardiovascular disorder
Clareo Health | Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®
